We have now extended these studies using in vitro stimulation of purified B cells from patients with ME/CFS by following changes in B cell immunophenotype, notably CD24 expression and that of the ectonucleotidases CD38, CD39, and CD73. This evidence concerns the gene CD38 and myalgic encephalomeyelitis/chronic fatigue syndrome.